United States
Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
Generics Bulletin Podcasts
From Norstella
Business
Citeline Podcasts
by Norstella
Chart positions today · United Kingdom
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Citeline Podcasts, try…
Pink Sheet Podcasts
From Norstella
The Readout Loud
Also in Business
Conversations in Drug Development
Also in Business
FDA Watch
Also in Business
Peptides With Michele
Also in Business
Ranking history · United Kingdom
No ranking history for this show in United Kingdom over the last 7 days.
Latest episodes
-
Strategic Intent: Can Blood Tests Break the Alzheimer’s Diagnosis Bottleneck?
October 20, 2026 · 29 minDisease-modifying Alzheimer’s treatments have arrived, but diagnosing the right patients at scale is still a major bottleneck. In this episode of Strategic Intent, Marion Webb (MedTech Insight) speaks with Dr. Soeren Mattke, research…
-
Off-Patent, On Record: Unlocking The Value Of Biosimilars Beyond Savings With IGBA’s Ana Gaunt
October 19, 2026 · 27 minIn the latest episode of Off-Patent, On Record, Generics Bulletin’s senior reporter Urtė Fultinavičiūtė talks to the International Generic and Biosimilar medicines Association’s secretary general Ana Gaunt to mark the start of Global…
-
Drug Fix: What Drove US FDA Generics Chief To Step Down And New Rare Disease Framework
October 16, 2026 · 28 minPink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss the reasons Iilun Murphy, director of the US Food and Drug Administration’s Office of Generic Drugs, decided to step down (:53)…
-
Scrip Chinese-Language Podcast - Oct. 14, 2026
October 15, 2026 · 18 min本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年10月9日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本周内容包括：中国带来的竞争威胁；第三季度并购活动降温；新型肺炎球菌疫苗竞争者；西班牙生物技术公司的战略；以及盐野义制药20亿美元的收购案。Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must…
-
Digital Health Roundup: BD’s $19Bn Tariff Deal, Longevity, GLP-1 Tools Chasing Proof
October 15, 2026 · 18 minIn this month's podcast, Shubham Singh discusses BD’s $19bn US investment deal for tariff relief; Brian Bossetta, NET Recovery’s stimulant-use device; George Underwood, Reset Health’s GLP-1 adherence data; and Marion Webb, Hillary Lin’s…
Show 7 more episodesShow fewer episodes
-
Scrip's Five Must-Know Things - Oct. 13, 2026
October 13, 2026 · 16 minJoin us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five Must-Know Things. This episode covers insights for the business…
-
Strategic Intent: Celebrity Marketing In The Age Of Promo Crackdown
October 13, 2026 · 27 minCan a celebrity campaign still work for a drug company when the FDA is watching every word? In this episode of Strategic Intent, Frank Watanabe, CEO of Arcutis Biotherapeutics, discusses the company’s latest brand awareness push and what…
-
Drug Fix: US FDA’s Peptide Drama, More Transparency, Ibogaine Clinical Trial Plans
October 9, 2026 · 41 minPink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, Senior Editor Sue Sutter and Senior Reporter Maaisha Osman discuss the drama unfolding at the US Food and Drug Administration related to a Health and Human…
-
Off-Patent, On Record: Navigating The Financial Strategy Behind Litigation With Sandoz’s Julia Pike
October 6, 2026 · 24 minIn the third episode of Off-Patent, On Record, Generics Bulletin’s senior reporter Urtė Fultinavičiūtė is joined by Sandoz’s head of IP Julia Pike to analyze the European intellectual property system, how it compares to the US, and the…
-
Strategic Intent: Using Agentic AI To Create ‘The Self-Driving Clinical Trial, Kind Of Like The Car’
October 6, 2026 · 33 minIn this Strategic Intent episode, In Vivo speaks with Ken Getz, executive director of the Tufts CSDD and research professor at the Tufts University School of Medicine, and Pamela Tanaerts, CMO and CSO at Medable, to discuss promising data…
-
Counting Self-Care’s Triple Win, With GSCF’s Greg Perry And Ben Carrick
October 5, 2026 · 56 minThe Global Self-Care Federation has updated its analysis of the health, social and economic value of self-care, using data from 155 countries. Savings to health systems are up 21% to around $144bn a year, and for the first time the…
-
Drug Fix: CMS Finalizes GLOBE Model And US FDA Adcomm, Personnel Changes
October 2, 2026 · 31 minPink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Senior Writer Cathy Kelly discuss the limited impact the US Centers for Medicare and Medicaid Services’ Global Benchmark for Efficient Drug Pricing (GLOBE) model…
About the show
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.